SkinnyRx vs Pallas Health: Oral tablets vs clinician-chosen plans
Fast verdict: SkinnyRx is focused on daily oral semaglutide tablets with FSA/HSA eligibility, free overnight shipping, and a starting price of as low as $249/mo, while Pallas Health offers a clinician-led program that can deliver FDA-approved pens or compounded semaglutide or tirzepatide beginning at $139 for the first month then $199/mo average for compounded semaglutide. Choose based on whether you prioritize an oral tablet and FSA/HSA use or clinician selection between brand and compounded options.
See SkinnyRx oral semaglutide plans
How SkinnyRx and Pallas Health differ at a glance
The most distinctive differences are price and billing cadence, medication format and options, clinician role and included provider care, and FSA/HSA or payment details. Below we compare those points using only the supplied facts.
Price structure and billing cadence
SkinnyRx lists oral semaglutide tablets as low as $249/mo. Pallas Health lists compounded semaglutide at $139 for the first month, then $597 every 12 weeks, which is a $199/mo average. Pallas also publishes cash-pay prices for FDA-approved brand medications separately. Pallas prices compounded plans by medication rather than by milligram, so titrating up does not increase the plan price; SkinnyRx presents a monthly figure and mentions Affirm Buy Now Pay Later as a split payment option. Both providers offer free or expedited shipping.
View Pallas Health plans and first-month pricing
Medication options and format
SkinnyRx emphasizes daily oral semaglutide tablets taken under the tongue as an alternative to injections. Pallas Health offers two routes from one intake: FDA-approved brand-name GLP-1 pens such as Wegovy, Ozempic, Zepbound and Mounjaro, or clinician-personalized compounded semaglutide and tirzepatide prepared in the USA when a brand medication is not the right fit. If you specifically want an oral tablet, the supplied evidence supports SkinnyRx; if you want a clinician to choose between brand pens and compounded injectables, the evidence supports Pallas Health.
Explore SkinnyRx oral semaglutide tablets
Clinician role, included care, and accessibility
SkinnyRx requires an online consultation and clinician review before a prescription is written and highlights ongoing support and dose adjustments from licensed providers. Pallas Health is 100% online with a US-licensed clinician personalizing the plan, and its plan price includes clinician review, ongoing check-ins and care-team messaging with no membership fee. Pallas notes asynchronous care in most states (43 of 50 need no video visit) and that eligibility is determined by a US-licensed clinician. Pallas also refunds in full if a clinician decides treatment is not right for you; SkinnyRx states prescriptions are subject to clinician review.
FSA/HSA eligibility, shipping and pharmacy notes
SkinnyRx explicitly states FSA/HSA eligible and FSA/HSA use is a meaningful financial advantage. Pallas Health is cash-pay only and does not bill insurance; it says treatment may be FSA/HSA-eligible with a Letter of Medical Necessity. Both providers offer expedited or overnight shipping and note that compounded medications are prepared by partner pharmacies. SkinnyRx states partner pharmacies perform third-party testing every 3 to 6 months confirming concentration within plus or minus 10 percent. Pallas states compounded medications are prepared by US-licensed compounding pharmacies and the medication you receive may differ in appearance from any product shown.
Comparison table: SkinnyRx vs Pallas Health
| Criteria | SkinnyRx | Pallas Health |
|---|---|---|
| Starting price | As low as $249/mo | $139 first month; then $199/mo avg for compounded semaglutide |
| Medication formats | Daily oral semaglutide tablets | FDA-approved brand-name pens or compounded semaglutide and tirzepatide |
| Clinician care included | Prescription after online consultation; ongoing support and dose adjustments | Clinician review, check-ins and messaging included in plan price |
| FSA/HSA use | FSA/HSA eligible | May be FSA/HSA-eligible with Letter of Medical Necessity; cash-pay only |
| Shipping | Free overnight shipping | Free expedited and discreet shipping |
| Compounded medication notes | Partner pharmacies do third-party testing every 3 to 6 months; compounded drugs are not FDA-approved | Compounded in the USA by compounding pharmacies; compounded drugs are not FDA-approved |
Safety, regulatory and refund points
Both sources include the regulatory note that compounded medications are not FDA-approved and are not reviewed by the FDA for safety, effectiveness or quality. SkinnyRx documents a cancellation and refund policy tied to prescription review timing and says you may cancel and receive a full refund any time before a licensed provider completes your prescription review; once fulfillment begins, orders become non-refundable. Pallas notes refunds if a clinician decides treatment is not right for you and emphasizes cancel-anytime for plans that renew every 12 weeks for compounded plans.
Start a Pallas Health intake and see clinician options
Conclusion: SkinnyRx vs Pallas Health
SkinnyRx centers on oral semaglutide tablets with FSA/HSA eligibility, free overnight shipping and a starting monthly figure of as low as $249/mo. Pallas Health centers on clinician choice between FDA-approved brand pens and compounded options, with compounded semaglutide pricing that starts at $139 for the first month then averages $199/mo and includes clinician care in the plan price. Use the comparison above to match what matters most to you.
Choose SkinnyRx if you want daily oral semaglutide tablets, FSA/HSA eligibility and free overnight shipping.
Choose Pallas Health if you want a clinician to select between brand-name pens and compounded semaglutide or tirzepatide, with provider care included and introductory compounded pricing starting at $139.